© The Financial Times Ltd 2015 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of May 22, 2015, the consensus forecast amongst 30 polled investment analysts covering Roche Holding Ltd. advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on Jun 02, 2003. The previous consensus forecast advised investors to hold their position in Roche Holding Ltd..
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 24 analysts offering 12 month price targets for Roche Holding Ltd. have a median target of 305.00, with a high estimate of 340.00 and a low estimate of 265.00. The median estimate represents a 9.75% increase from the last price of 277.90. View Full Financials
In 2014, Roche Holding AG reported a dividend of 8.00 CHF, which represents a 2.56% increase over last year. The 28 analysts covering the company expect dividends of 8.32 CHF for the upcoming fiscal year, an increase of 3.98%. View Full Financials
|Div growth (TTM)||+2.56 %|
On Jul 24, 2014, Roche Holding Ltd. reported semi annual 2014 earnings of 7.57 per share. This result was in line with the consensus of the 4 analysts following the company and under-performed last year's results for the same period by 0.13 %.
The next earnings announcement is expected on Apr 22, 2015. View Full Interim Financials
|Average growth rate||+2.78 %|
Roche Holding Ltd. reported annual 2014 earnings of 14.29 per share on Jan 28, 2015. View Full Annual Financials
|Average growth rate||+5.96 %|
Roche Holding AG reported semi annual 2014 revenues of 24.49bn. This bettered the 24.16bn consensus of the 4 analysts covering the company. This was 4.27% above the prior year's period results. View Full Interim Financials
|Average growth rate||+1.54 %|
Roche Holding AG had revenues for the full year 2014 of 47.46bn. This was 1.46% above the prior year's results. View Full Annual Financials
|Average growth rate||+0.21 %|